Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

Kansas Board of Regents

Status and phase: Completed; Phase 2

Conditions: Substance-Related Disorders; Cocaine-Related Disorders

Treatments: Drug: Carbamazepine

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; NIH

Identifiers

NCT00000217

NIDA-06954-1

R18-06954-1

R18DA006954 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Sex: All

Ages: 18 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.